Fingerprint
Dive into the research topics of 'Determining the Comparative Value of Pharmaceutical Risk-Sharing Policies in Non–Small Cell Lung Cancer Using Real-World Data'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Determining the Comparative Value of Pharmaceutical Risk-Sharing Policies in Non–Small Cell Lung Cancer Using Real-World Data
Marscha S. Holleman*, Carin A. Uyl-de Groot, Stephen Goodall, Naomi van der Linden
*Corresponding author for this work
Research output: Contribution to journal › Article › Scientific › peer-review
9
Citations
(Scopus)